Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Sutro Biopharma, Inc. (STRO) had Receiveable Turnover of 2.47 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$9.69M |
|
$-56.86M |
|
-- |
|
$9.69M |
|
$58.15M |
|
$-48.46M |
|
$-8.40M |
|
$-56.86M |
|
$-56.86M |
|
$-56.86M |
|
$-56.86M |
|
$-56.86M |
|
$-56.86M |
|
$-48.46M |
|
$-47.31M |
|
84.87M |
|
84.87M |
|
$-0.67 |
|
$-0.67 |
|
| Balance Sheet Financials | |
$182.11M |
|
$13.35M |
|
$27.55M |
|
$209.66M |
|
$71.89M |
|
-- |
|
$225.03M |
|
$296.93M |
|
$-87.27M |
|
$-87.27M |
|
$-87.27M |
|
85.10M |
|
| Cash Flow Statement Financials | |
$-150.80M |
|
$26.31M |
|
$0.11M |
|
$191.16M |
|
$66.78M |
|
$-124.38M |
|
$12.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-499.94% |
|
-499.94% |
|
-- |
|
-586.58% |
|
-586.58% |
|
$-152.31M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
|
Receiveable Turnover |
2.47 |
36.42 |
|
65.15% |
|
65.15% |
|
-27.12% |
|
65.15% |
|
$-1.03 |
|
$-1.79 |
|
$-1.78 |
|